malaria - Oxford University and Serum Institute of India tie-up delivers 'high efficacy' malaria vaccine
The vaccine has been licensed for use in Ghana by Africa’s Food and Drugs Authority
Source: telegraphindia.com
Page 14 - Johnc Jacobs News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Johnc Jacobs. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Johnc Jacobs Today - Breaking & Trending Today
R21/Matrix-M™ malaria vaccine developed by University of Oxford receives regulatory clearance for use in Ghana
The University of Oxford-developed and Serum Institute of India PvT Ltd (SIIPL)- manufactured and scaled up R21/Matrix-MTM malaria vaccine, leveraging Novavax’s adjuvant technology, has been licensed for use in Ghana by the country’s Food and Drugs Authority.
Source: ox.ac.uk
Oxford University Serum Institute of India tie-up delivers 'high efficacy' malaria vaccine
(This story has not been edited by THE WEEK and is auto-generated from a PTI
Source: theweek.in
Oxford University, SII tie-up delivers 'high efficacy' malaria vaccine
"It is our intention to unlock the potential of our adjuvant, both in the near term and over time, to continue to improve public health."
Source: siasat.com
Oxford University, Serum Institute of India tie-up delivers 'high efficacy' malaria vaccine
The R21/Matrix-M vaccine, leveraging Novavax's adjuvant technology, has been approved for use by Africa's Food and Drugs Authority in Ghana for children aged 5 to 36 months - the age group at the highest risk of death from malaria.
Source: moneycontrol.com